| September 22-26, 2019 │ Foz do Iguacu, Brazil Foz do Iguacu 2019 Congress |
|||
|
|
|||
| yyyy-mm-dd | Type | Link | Title and Presenters |
|
|
|||
| 2019-9-23 07:45am | Anti-Infective |  |
Clinical use of PK/PD for individualization of antibiotic therapy Birgit Koch, The Netherlands |
|
|
|||
| 2019-9-23 07:45am | Pharmacogenetic of Tamoxifen Symposium | |
Prospective studies of tamoxifen pharmacogenetics and metabolism: what have we learned Jesse Swen, The Netherlands |
|
|
|||
| 2019-9-23 07:45am | Pharmacogenetic of Tamoxifen Symposium | |
PGx of tamoxifen: metastatic advanced patients in Japanese population Yusuke Tanigawara, Japan |
|
|
|||
| 2019-9-23 08:45am | TDM Symposium in Oncology: Exposure-response Relationships of Commonly used Mabs | |
TDM of biologics in oncology – what can we learn from biologics used in inflammatory disease and how to apply in oncology? Annick de Vries, The Netherlands |
|
|
|||
| 2019-9-23 08:45am | TDM Symposium in Oncology: Exposure-response Relationships of Commonly used Mabs | |
Exposure-response relationships of commonly used Mab Fabienne Thomas-Jean, France |
|
|
|||
| 2019-9-23 08:45am | Immunosuppressive Drugs Symposium: TDM of Immunosuppressive Drugs-Personalized Therapy |
|
Tacrolimus intracellular concentrations: Improving patient and graft care Florian Lemaitre, France |
|
|
|||
| 2019-9-23 08:45am | Immunosuppressive Drugs Symposium: TDM of Immunosuppressive Drugs-Personalized Therapy |
|
Update of immunosuppressive drugs TDM in pediatric population Tomoyuki Mizuno, USA |
|
|
|||
| 2019-9-23 08:45am | Immunosuppressive Drugs Symposium: TDM of Immunosuppressive Drugs-Personalized Therapy |
|
Insight anti-infective drugs in transplant recipients Andrea Dinlz, Brazil |
|
|
|||
| 2019-9-23 08:45am | Biologics Symposium: Proactive Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Diseases: Induction treatment and cost | |
Induction anti-TNF concentrations and primary nonresponse in adult IBD patients Niels Vande Casteele, USA |
|
|
|||
| 2019-9-23 08:45am | Biologics Symposium: Proactive Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Diseases: Induction treatment and cost |
|
Is there a place for therapeutic drug monitoring of drugs other than infliximab for inducing response in patients with inflammatory bowel diseases? Erwin Dreesen, Belgium |
|
|
|||
| 2019-9-23 08:45am | Biologics Symposium: Proactive Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Diseases: Induction treatment and cost |
|
Financial implications of anti-TNF therapeutic drug monitoring Murray Barclay, New Zealand |
|
|
|||
| 2019-9-23 12:15pm | Industry Workshop – Waters Symposium |
|
Mass spectrometry toxicology screening approaches and a case study in Brazil Michelle Wood, Waters UKJosé Luiz da Costa, Unicamp, Brazil |
|
|
|||
| 2019-9-23 03:15pm | Young Scientists Symposium | |
Alternative sampling strategies to support therapeutic drug monitoring of anti-TB drugs in RB endemic areas Samiksha Ghimire, The Netherlands |
|
|
|||
| 2019-9-23 03:15pm | Young Scientists Symposium | |
Study design and reporting matters: why IATDMCT members’ work was not included in important systematic reviews of TDM Jana Stojanova, Chile |
|
|
|||
| 2019-9-23 03:15pm | Young Scientists Symposium | |
Challenges and opportunities for model-informed precision dosing in very young children Tomoyuki Mizuno, USA |
|
|
|||
| 2019-9-23 03:15pm | Symposium: Therapeutic Drug Monitoring in developing countries | |
Therapeutic monitoring of immunosuppressive drugs Renato Foresto, Brazil |
|
|
|||
| 2019-9-23 03:15pm | Symposium: Therapeutic Drug Monitoring in Developing Countries | |
How can we bridge the gap between developed and developing countries in TDM? Paula Schaiquevich, Argentina |
|
|
|||
| 2019-9-23 03:15pm | Symposium: Therapeutic Drug Monitoring in Developing Countries | |
Improving the old and in with the new: the expanding role of TDM in the management of mycobacterium tuberculosis Andres Felipe Zuluaga, Columbia |
|
|
|||
| 2019-9-23 03:15pm | Symposium: Anti-infective Agents and Therapeutic Drug Monitoring: the ultimate precision medicine when no two patients are alike | |
The role of the laboratory in achieving personalised anti-infective TDM Danijela Kocic, Australia |
|
|
|||
| 2019-9-23 03:15pm | Symposium: Anti-infective Agents and Therapeutic Drug Monitoring: the ultimate precision medicine when no two patients are alike | |
Renal replacement therapy and antimicrobial therapy: a knowledge vacuum Jan-Willem Alffenaar, The Netherlands |
|
|
|||
| 2019-9-23 03:15pm | Symposium: Anti-infective Agents and Therapeutic Drug Monitoring: the ultimate precision medicine when no two patients are alike | |
Therapeutic drug monitoring and safety of voriconazole therapy in patients with hepatic disease Miao Yan, China |
|
|
|||
| 2019-9-24 07:45pm | Alternative Sampling Strategies Symposium | |
Dried blood sampling techniques distinct from dried blood samples: what’s available and what’s the status? Christophe Stove, Belgium |
|
|
|||
| 2019-9-24 07:45pm | Immunosuppressive Drugs Symposium | |
Biomarkers in transplantation Pierre Marquet, France |
|
|
|||
| 2019-9-24 08:45pm | Anti-infective Symposium: Not Just Tuberculosis: the therapeutic challenges of acid-fast organisms | |
Nocardia, the ultimate opportunist Debbie Marriott, Australia |
|
|
|||
| 2019-9-24 08:45pm | Anti-infective Symposium: Not Just Tuberculosis: the therapeutic challenges of acid-fast organisms | |
Mycobacterium abscessus: a rising pathogen Michael Neely, USA |
|
|
|||
| 2019-9-24 08:45pm | Anti-infective Symposium: Not Just Tuberculosis: the therapeutic challenges of acid-fast organisms | |
Non-tuberculous mycobacteria: does TDM have a place? Jan-Willem Alffenaar, The Netherlands |
|
|
|||
| 2019-9-24 08:45pm | New Psychotropic Drugs Symposium | |
Techniques for toxicokinetic studies of NPS Markus Meyer, Germany |
|
|
|||
| 2019-9-24 08:45pm | New Psychotropic Drugs Symposium | |
Epidemiology of NPS consumption by oral fluid analysis Jose Luiz da Costa, Brazil |
|
|
|||
| 2019-9-24 08:45pm | New Psychotropic Drugs Symposium | |
Detection of NPS requires NPS (New Perfomant Strategies) Christophe Stove, Belgium |
|
|
|||
| 2019-9-24 08:45pm | Clinical Use of Precision Dosing Software Symposium | |
Current and future developments in model-Informed precision dosing Ron Keizer, USA |
|
|
|||
| 2019-9-24 08:45pm | Clinical Use of Precision Dosing Software Symposium | |
Chances and challenges for implementation of precision dosing software from a pharmacometric perspective Sebastian Wicha, Germany |
|
|
|||
| 2019-9-24 12:15pm | Industry Workshop – Symposium Shimadzu | |
Fully automated sample preparation procedure for TDM by liquid chromatography tandam mass spectrometry Marcos Albieri Pudenzi, Shimadzu |
|
|
|||
| 2019-9-25 07:45am | Clinical Toxicology Symposium | |
Immunotoxicity: drug-induced and herbal-induced hypersensitivity reactions Manuela Neuman, Canada |
|
|
|||
| 2019-9-25 07:45am | Clinical Toxicology Symposium | |
Oxidative stress and inflammation in kidney transplantation: the effect of immunosuppression Eberhard Wieland, Germany |
|
|
|||
| 2019-9-25 07:45am | Toxicology and Environmental Health Symposium | |
Metals/lead poisoning in the 21st century – changing paradigms: serum vs. whole blood lead concentrations Souleiman El Balkhi, France |
|
|
|||
| 2019-9-25 07:45am | Toxicology and Environmental Health | |
Lead: The human risk from drinking water David Kinniburgh, Canada |
|
|
|||
| 2019-9-25 08:45am | Pharmacogenetic PGx in Oncology Symposium | |
DPYD and 5-FU Teun van Gelder, The Netherlands |
|
|
|||
| 2019-9-25 08:45am | Pharmacogenetic PGx in Oncology Symposium | |
UGT1A1 and beyond: Can a validated molecular signature be used to guide the prescription of irinotecan with associated therapies in advanced colorectral or pancreatic cancers? Jean Christophe Boyer, France |
|
|
|||
| 2019-9-25 08:45am | Pharmacogenetic PGx in Oncology Symposium | |
Tyrosine kinase inhibitors and PGx of ABCG2 Tomohiro Terada, Japan |
|
|
|||
| 2019-9-25 08:45am | Alternative Sampling Strategies: What’s new in Microsampling Symposium | |
Adduct monitoring in blood microsamples Lisa Delahaye, Belgium |
|
|
|||
| 2019-9-25 08:45am | Alternative Sampling Strategies: What’s new in Microsampling Symposium | |
Drug monitoring via fingerprints Melanie Bailey, UK |
|
|
|||
| 2019-9-25 08:45am | Alternative Sampling Strategies: What’s new in Microsampling Symposium | |
IATDMCT method validation guidelines for dried blood spot assays Jan-Willem Alffenaar, The Netherlands |
|
|
|||
| 2019-9-25 11:00am | Plenary Session | |
Pharmacology and Toxicology of New Psychoactive Substances Hans H. Maurer, Germany |
|
|
|||
| 2019-9-25 12:15pm | Industry workshop – Thermo Scientific Symposium | |
Performing mass spectrometry based analysis with confidence: robus, reliable, sensitive assays for toxicology Xlaolel Xie, Manager, Clinical Research Vertical Market |
|
|
|||
| 2019-9-25 03:15pm | Mass Spectrometry in Clinical and Forensic Toxicology Symposium | |
Qualitative and quantitative solutions in 24/7 toxicological analysis Markus Meyer, Germany |
|
|
|||
| 2019-9-25 03:15pm | Mass Spectrometry in Clinical and Forensic Toxicology Symposium | |
High-resolution mass spectrometry for fentanyl analog screening, confirmation and discovery Michelle Wood, UK |
|
|
|||
| 2019-9-25 03:15pm | Mass Spectrometry in Clinical and Forensic Toxicology Symposium | |
Ready to use mass spectrometry-based solutions for toxciology Diego Assis, Brazil |
|
|
|||
| 2019-9-25 03:15pm | Toxicology & Environmental Health, Environmental Pollutants and Health Outcomes: an Overview of Recent Evidence Symposium | |
Bisphenola and metabolic diseases Nicolas Venisse, France |
|
|
|||
| 2019-9-25 03:15pm | Toxicology & Environmental Health, Environmental Pollutants and Health Outcomes: an Overview of Recent Evidence Symposium | |
Pesticide environmental exposure: molecular and biochemical biomarkers and morphometric parameters in pregnant women, placenta and newborn Gladis Magnarelli, Argentina |
|
|
|||
| 2019-9-25 03:15pm | Toxicology & Environmental Health, Environmental Pollutants and Health Outcomes: an overview of Recent Evidence Symposium | |
Effects of a mixture of persistent organic pollutants on the thyroid function of a Belgian population Patrice Dufour, Belgium |
|
|
|||
| 2019-9-25 03:15pm | Pharmacometrics Symposium | |
R-shiny tools for pharmacometrics in drug development Patrick Nolain, France |
|
|
|||
| 2019-9-25 03:15pm | Pharmacometrics Symposium | |
Development and applications of pharmacometric tools for routine clinical practices Jean Baptiste Woillard, France |
|
|
|||
| 2019-9-25 03:15pm | Pharmacometrics Symposium | |
Implementing model-based dosing in clinical practice Birgit Koch, The Netherlands |
|
|
|||
| 2019-9-25 5:00 pm |
|
IATDMCT 2019 Annual General Meeting | |
|
|
|||
IATDMCT, 4 Cataraqui Street Suite 310
Kingston, ON, K7K 1Z7, Canada
